Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment

202332 citationsletter

Authors

Katharina S. Shaw · University of Pennsylvania

Diana B. Reusch · Brigham and Women's Hospital

Rochelle Castillo · Brigham and Women's Hospital

Kimberly B. Hashemi · Brigham and Women's Hospital

Robert P. Sundel · Boston Children's Hospital

Fatma Dedeoğlu · Boston Children's Hospital

Ruth Ann Vleugels

Abstract

This case report describes a 14-year-old girl with juvenile dermatomyositis who presented with a 6-year history of a pruritic, photosensitive eruption involving her face, neck, trunk, and extremities and was successfully treated with anifrolumab.

Topics & Keywords

Inflammatory Myopathies and Dermatomyositis Eosinophilic Disorders and Syndromes Immunodeficiency and Autoimmune Disorders

Publication Details

Published in: JAMA Dermatology

Volume 160, Issue 2, pp. 237-237

DOI: 10.1001/jamadermatol.2023.4744

Field-Weighted Citation Impact: 6.87

Command Palette

Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment

Authors

Abstract

Topics & Keywords

Publication Details